Difference between revisions of "Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5 (Q9864)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Published In Name String (P102): Clinical Cancer Research, #quickstatements; #temporary_batch_1590006349955)
(‎Created claim: Tenth Author string (P158): Leong Ruby, #quickstatements; #temporary_batch_1590155687727)
 
(9 intermediate revisions by the same user not shown)
Property / Volume
 +
25
Property / Volume: 25 / rank
 +
Normal rank
Property / title
 +
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia (English)
Property / title: FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia (English) / rank
 +
Normal rank
Property / Page(s)
 +
6021-6025
Property / Page(s): 6021-6025 / rank
 +
Normal rank
Property / Fourth Author string
 +
Zhuang Luning
Property / Fourth Author string: Zhuang Luning / rank
 +
Normal rank
Property / Fifth Author string
 +
Del Valle Pedro L.
Property / Fifth Author string: Del Valle Pedro L. / rank
 +
Normal rank
Property / Sixth Author string
 +
Przepiorka Donna
Property / Sixth Author string: Przepiorka Donna / rank
 +
Normal rank
Property / Seventh Author string
 +
Shen Yuan-Li
Property / Seventh Author string: Shen Yuan-Li / rank
 +
Normal rank
Property / Eighth Author string
 +
Sheth Christopher M.
Property / Eighth Author string: Sheth Christopher M. / rank
 +
Normal rank
Property / Ninth Author string
 +
Liu Chao
Property / Ninth Author string: Liu Chao / rank
 +
Normal rank
Property / Tenth Author string
 +
Leong Ruby
Property / Tenth Author string: Leong Ruby / rank
 +
Normal rank

Latest revision as of 13:55, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Norsworthy Kelly J.
    0 references
    By Kunthel
    0 references
    Subramaniam Sriram
    0 references
    20
    0 references
    0 references
    2019
    0 references
    Clinical Cancer Research
    0 references
    25
    0 references
    FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia (English)
    0 references
    6021-6025
    0 references
    Zhuang Luning
    0 references
    Del Valle Pedro L.
    0 references
    Przepiorka Donna
    0 references
    Shen Yuan-Li
    0 references
    Sheth Christopher M.
    0 references
    Liu Chao
    0 references
    Leong Ruby
    0 references